TargetMol

Iobitridol

Product Code:
 
TAR-T19949
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1
❮❯

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T19949-5mg5mg£850.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
How to order with us   Contact us
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Iobitridol is a reagent of biovhemical.
CAS:
136949-58-1
Formula:
C20H28I3N3O9
Molecular Weight:
835.169
Purity:
0.98
SMILES:
CN(C[C@@H](O)CO)C(=O)c1c(I)c(NC(=O)C(CO)CO)c(I)c(C(=O)N(C)C[C@H](O)CO)c1I

References

1. Kim YS, Yoon SH, Choi YH, Park CM, Lee W, Goo JM. Nausea and vomiting after exposure to non-ionic contrast media: incidence and risk factors focusing on preparatory fasting. Br J Radiol. 2018 Apr 25:20180107. doi: 10.1259/bjr.20180107. [Epub ahead of print] PubMed PMID: 29694239. 2. Liu Y, Ji X, Liu J, Tong WWL, Askhatova D, Shi J. Tantalum Sulfide Nanosheets as a Theranostic Nanoplatform for Computed Tomography Imaging-Guided Combinatorial Chemo-Photothermal Therapy. Adv Funct Mater. 2017 Oct 19;27(39). pii: 1703261. doi: 10.1002/adfm.201703261. Epub 2017 Aug 21. PubMed PMID: 29290753; PubMed Central PMCID: PMC5743210. 3. Piacentino F, Fontana F, Micieli C, Angeretti MG, Cardim LN, Coppola A, Molinelli V, Piffaretti G, Novario R, Fugazzola C. Nonenhanced MRI Planning for Endovascular Repair of Abdominal Aortic Aneurysms: Comparison With Contrast-Enhanced CT Angiography. Vasc Endovascular Surg. 2018 Jan;52(1):39-45. doi: 10.1177/1538574417740508. Epub 2017 Nov 21. PubMed PMID: 29162027. 4. B?ning G, Kahn JF, Kaul D, Rotzinger R, Freyhardt P, Pavel M, Streitparth F. CT follow-up in patients with neuroendocrine tumors (NETs): combined radiation and contrast dose reduction. Acta Radiol. 2018 May;59(5):517-526. doi: 10.1177/0284185117726101. Epub 2017 Aug 8. PubMed PMID: 28786299.